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Abstract 
 
Background: Posterior urethral valves are the most common cause of infra-vesical obstruction in the male child. A 
posterior urethral valve (PUVs) represents the most common etiology for congenital urethral obstruction and the 
most common congenital cause for bilateral renal obstruction and somatic growth retardation. It is also the most 
common cause of obstructive uropathy leading to childhood renal failure. With an estimated incidence of 1/5000 to 
1/8000 male births, they account for 10% of all prenatally diagnosed urinary obstructions. The aim & objective of 
present study is to find out the incidence, age & modes of clinical presentation relevant investigations and different 
management in cases with diagnosed posterior urethral valve and its short term outcome. Materials & Methods: 
Study was carried out in MGM Medical College & LSK Hospital Kishanganj Bihar India. It is a retrospective study 
of the patients who were managed from September 2016 to August 2018 and followed up in our department. 
Results: Out of 50 patients, 100% patients presented with poor urinary poor urinary stream followed by dribbling of 
urine and palpable bladder, 54% presented with recurrent UTI. About 66% patients had presented with fever and 7 
patients presented with features of renal failure. We had; done primary cystoscopic valve fulguration in 41 cases 
(82%) and vesicostomy followed by cystoscopic fulguration in rest of 9 cases (18%). Conclusion: Posterior urethral 
valve is a dynamic disease that can have lifelong effects on bladder. These patients need long term follow up care to 
monitor and treat the effects of altered bladder compliance. 
Keywords: Posterior urethral valve; Bladder dysfunction; Ureteric reflux; Hyperreflexia; Cystourethrography
Introduction 
 
Posterior urethral valves are the most common cause of 
infravesical obstruction in the male child[1]. 
Posterior urethral valves (PUVs) represents the most 
common etiology for congenital urethral obstruction 
and the most common congenital cause for bilateral 
renal obstruction. With an estimated incidence of 
1/5000 to 1/8000 male births, they account for 10% of 
all prenatally diagnosed urinary obstructions[2,3]. It is 
also the most common cause of obstructive uropathy 
leading to childhood renal failure[4].  
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Posterior urethral valves are unique to male children 
and there is no parallel urethral anomalies in girls, 
similar to posterior urethral valves in boys. The 
widespread use of pre-natal ultrasound has now 
provided the opportunity too many patients with valves 
well before birth[5].It has become clear that bladder 
outlet obstruction also affects the development and 
function of urinary bladder.The incidence ranges from 
1:8000 (Casale AJ et al 1990)[6] to 1:25000 live male 
birth (Atwell-JD et al 1983O)[1]. Obstruction of the 
fetal lower urinary tract is a rare disorder, affecting 2.2 
per 10,000 births. PUV, while being the most common 
cause of lower urinary tract obstruction in males, are a 
rare disorder, affecting only 1 in 4000–7500 infants, 
and there is a disproportionately elevated incidence in 
African-Americans and children with Down’s 
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syndrome. Despite their rarity, PUV present such a 
severe insult to the upper urinary tract that they account 
for almost 17% of children with end-stage renal 
failure[7,8]. Although most cases are diagnosed at 
childhood, (the majority are diagnosed before 10 years 
of age), it may also present at any age.The commonest 
clinical presentation is urinary symptoms (poor urinary 
stream followed by dibbling of urine) and severe 
septicemia, respiratory distress and failure to thrive[4]. 
Generalized distention of abdomen is more common in 
younger age group especially in neonate along with 
urinary ascitis[5]. The incidence of palpable kidney, 
hypertrophied bladder on bimanual palpation was 
documented to be higher. Posterior urethral valves may 
be associated with upto 10% of severe prenatally 
diagnosed hydronephrosis[9].Prenatal ultrasound 
screening of PUV has significantly increased early 
diagnosis and management of this pathology in most 
developed societies. In fact, PUV are now commonly 
diagnosed by the postnatal evaluation of infants who 
had prenatal hydronephrosis[10].Langenbeck in 1802 
is credited with the first description of such valves. Dr. 
H. Hampton young is generally given credit for first 
clear description and classification of posterior urethral 
valves (Young et al 1919). He recognised three distinct 
varieties of congenital proximal urethral obstruction 
and classified these as 
Type- I, II, III (Young HH, Frontz WA et al 1919)[11]. 
Classification of posterior urethral valves[12] 
Type I: Posterior mucosal folds distal to the 
verumontanum. 
Type II: Mucosal folds that diverge from 
verumontanum towards the bladder neck. 
Type III: Valves of the diaphragmatic or the annular 
type. 
Stephens (1983) suggested the existence of an 
additional type of proximal urethral obstruction which 
he termed as Type-IV valves (Stephens-FD et al 
1983)[13]. The most typical PUV is presented in 
neonates with history of prenatal bilateral 
hydronephrosis or in infants with acute pyelonephritis 
associated with massive VUR. This group of PUV is 
easy to be diagnosed by typical findings in voiding 
cystourethrography (VCUG) and endoscopy for 
confirming valve like structure in the posterior urethra. 
In contrast, there is another group of PUV which is 
elusive and overlooked easily in VCUG even if it 
contributes to VUR or detrusor overactivity. Until 
recently there has been no reference standard based on 
findings in VCUG and endoscopy[14,15]. 
Initial continuous catheter drainage and 
eventual management by valve resection, avulsion or 
ablation could ameliorate the obstructive uropathy. 
However, it has been noted that even after surgical 
treatment of valves; about 70% of older children and 
adolescent boys continue to have persistent bladder 
dysfunction with long term morbidity and 
ESRD[10,16,17]. In a resource poor economy like 
ours, public enlightenment, early diagnosis, and prompt 
institution of management would go a long way in 
improving initial and long-term outcome of 
PUV[17].At present, primary endoscopic valve 
ablation is the standard method to treat the vast 
majority of posterior urethral valves in children[5]. 
The bladder dynamics change with growth of 
the baby and hypertonicity decreases with time 
following valve ablation while hyperreflexia persist 
leading to bladder dysfunction and urinary 
incontinence. Patients were kept in strict follow up to 
prevent long term complication. The aim & objective 
of present study is to find out the incidence, age & 
modes of clinical presentation relevant investigations 
and different management in cases with diagnosed 
posterior urethral valve and its short term outcome. 
 
Methods & patients 
 
About 50 cases with PUV were enrolled in the 
study period mentioned above. Paediatric patients of < 
12 years of age attending in paediatric surgery OPD or 
admitted in the indoor of Mata Gujri Memorial 
Medical College and L.S.K. Hospital Kishanganj, 
Bihar with symptoms suggestive of obstructive 
uropathy were selected for the study. A detailed 
history, general examination, per abdomen 
examination, examination of external genitalia, urine, 
hematological, and biochemical examination, 
ultrasonography, voiding cystourethrogram, intra 
venous urography and renal scan was done.  
Treatment protocol at our centre is: initial 
treatment is intravenous fluid, urinary catheter, 
correction of acid base balance and electrolyte, detailed 
urinary analysis and intravenous antibiotics. MCU was 
being done once C/S was reported as sterile or after 
infection was controlled. 
Operative Management: The patient was then 
scheduled for definitive procedure by diagnostic 
cystoscopy and cystoscopic valve fulguration. We 
follow up the cases of PUV initially at monthly internal 
for first 3 months with routine examination & C/S 
report and blood urea and serum creatinine report along 
with ultrasonography of abdomen and KUB. The way 
of assessment of prognosis was re-examination for pus 
cells per high power field (HPF) and blood urea, serum 
creatinine estimation. 
In our follow-up clinic we advise the following 
investigations. 
1. Blood Urea and serum creatinine 
 
Asian Pac. J. Health Sci., 2019; 6(2):58-65                                            e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Prayana Kunal et al                             ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2019;6(2):58--65                               60 
www.apjhs.com       
 
2. Routine urine examination and C/S if necessary, 
every month for 1st 3 months and after 3 months if C/S 
report sterile and then after 6 months and then yearly 
3. MCU was advised after 6 months to assess VUR 
4. USG- KUB was advised after 6 months for 
evaluation of the size of kidneys, ureters and bladder 
for VUR and post void residual urine volume 
5. DTPA renal scan was advised after 6 months in 
cases where there was persistent high serum creatinine 
level, even after urinary diversion or in cases where 
USG reveals definitive evidence of cystic dysplasia. 
6. Urodynamic study was done where serum creatinine 
level remains above 2 mg% but below 5 mg% or in 
patients having residual symptoms after adequate 
primary valve ablation. 
Results 
 
A total 50 cases of PUV were admitted to the Department of Surgery, M.G.M. Medical College & L.S.K. 
Hospital, Kishanganj, Bihar, from September 2016 to August 2018. Out of this 32 patients were admitted in the first 
two years and the rest of the 18 cases were admitted at rest of the study period. This accounts for 4.1 per 1000 
surgical OPD cases of our department.  
 
Table 1: Showing Age at Presentation (n = 50) 
 
Group Age at presentation No. of cases Percentage (%) 
I  < 1 month 7  14 
II  1 month – 2years 11 22 
III  2years – 5 years 22  44 
IV  5 years – 12 years 10 20 
In our study 14% patients presented within 1 month, 22% patients presented within 1 month – 2 year, 44% 
patients were in the age group of 2-5 years, and 20% were between 5 and 12 years of age. The youngest child 
presented at the age of 24 days and the oldest one at the age of 12 years. One of our patients was diagnosed 
antenatally, incidentally on routine USG screening [Table 1]. 
Table 2: Showing Symptoms at presentation (n = 50) 
 
Urinary Symptoms No. % Non-Urinary Symptoms No. % 
Poor urinary stream followed by dribbling 50 100 Abdominal distension 
 
21 42 
a) since birth 39 78 Abdominal pain 17 34 
b) for the last 3 months to 1 yr. 6 12 Vomiting 19 38 
Palpable bladder 50 100 Pallor 25 50 
Bilateral palpable kidneys 6 12 Edema 2 4 
Unilateral palpable kidneys 3 6 Failure to thrive 15 30 
Recurrent UTI 27 54 Fever 33 66 
  Respiratory distress 5 10 
Irritability 13 26 
Constipation 3 6 
 
In our series the common presenting features 
in neonates and infants were poor urinary stream 
followed by dribbling of urine, retention of urine, 
palpable bladder and irritability. About 100% patients 
presented with poor urinary poor urinary stream 
followed by dribbling of urine and palpable bladder, 
12% patients presented with bilateral palpable kidneys, 
6% patients presented with unilateral palpable kidneys, 
54% presented with Recurrent UTI. About 42% 
patients presented with abdominal distension, 34% 
with abdominal pain, 38% patients presented with 
nausea or vomiting, 50% patients presented with pallor, 
66% patients presented with fever, 26% patients 
presented with irritability, 10% patients presented with 
respiratory distress, 4% patients presented with edema 
and 6% presented with constipation. Seven patients 
presented with features of renal failure (urea ranged 
from 60 mg/dl to 250 mg/dl and serum creatinine 
ranged from 2.3 mg/dl to 7 mg/dl) and one of them 
presented with features of renal rickets [Table 2].
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Table 3: Showing incidence of associated anomalies (n = 50) 
 
Associated Anomalies Numbers Percentage (%) 
Cleft lip and cleft palate 1  
 
 
18 
Umbilical hernia with right sided congenital hydrocele 1 
Urachal fistula 1 
Bilateral CTEV with bilateral congenital dislocation of hip 1 
Spina bifida (S1) 1 
Genu valgum 1 
Balanitis xerotica obliterans 1 
Down’s syndorme 1 
Patulous anus 1 
Patulous anus was detected in 1 patient as 
mother complaint of constipation of her baby and per 
rectal examination revealed this finding. Anorectal 
manometry done showed normal study. Balanitis 
xerotica obliterans was treated by circumcision. Repair 
of cleft lip and palate was done. Herniotomy was done 
in patient with congenital hydrocele and he is waiting 
for repair of umbilical hernia. Release and lengthening 
of tendon was done in patient with CTEV. Urachal 
fistula was treated by excision. The boy with Down 
syndrome is under our supervision. 
 
Table 4: Showing the renal function status at the time of presentation (n = 50) 
 
Age 
Gr. 
No. Blood Urea (mg %) Serum Creatinine (mg %) 
>40-100 >100-200 >200 1-2 >2-3 >3 
  No. % No. % No. % No. % No. % No. % 
I 7 2 28.5 3 43 2 28.5 2 28.6 2 28.6 3 41.2 
II 11 2 18.2 5 45.5 4 36.3 5 45.4 3 27.27 3 27.27 
III 22 13 59 4 18.1 5 22.9 16 72.7 4 18.2 2 9.1 
IV 10 6 60 2 20 2 20 6 60 2 20 2 20 
 
At presentation blood urea and serum creatinine were raised in all patients. Creatinine level between 1-2 
mg/dl was in 29 patients (58%), between >2-3 mg/dl in 11 patients (22%) and >3 mg/d in 10 patients (20%). The 
following are the complications in our series following primary cystoscopic fulguration or cystoscopic fulguration 
followed by closure of vesicostomy [Table 4]. 
 
Table 5: Showing complications following valve ablation (n = 50) 
 
Complication Age Group Total (n = 50) % 
 Group I Group II Group III Group IV No. % 
Retention of urine - - 1 - 1 2 
Poor stream and 
straining 
2 1 - - 3 6 
Persistent septicemia - 1 - 1 2 4 
Urethral stricture - - 1 - 1 2 
 
Table 6: Showing mode of treatment (n = 50) 
 
 Total no. Primary valve 
ablation 
Urinary diversion (vesicostomy) followed 
by valve ablation 
< 1 month 7 7 0 
1 month to 2 years 11 7 4 
2 years to 5 years 22 19 3 
5 years to 12 years 10 8 2 
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Table 7: showing serum creatinine level at presentation and on subsequent follow-up [n=50] 
 1-2 mg/dl 2-3 mg/dl > 3 mg/dl Total 
At presentation 29 11 10 50 
1 month 39 6 5 50 
1 Year 41 2 0 43 
2 Years 39 1 0 40 
 
On routine examination of urine plenty of pus 
cells and positive urine culture were shown in 27 
patients (54%). Most common organism was E.coli. 
MCU was performed in all cases and all of them 
showed dilated and elongated posterior urethra. 
Irregular margin and trabeculations of the bladder was 
seen in 30 patients (60%). Multiple sacculations and 
diverticulae were seen in 25 patients (50%). 
Vesicoureteric reflux was noted in 19 patients (38%) at 
presentation of which bilateral reflux were present in 
11 patients (22%). Among them 8 cases of unilateral 
reflux, right side was affected in 3 cases and left side in 
5 cases. 5 cases showed severe reflux (grade IV and V) 
[Table 5]. USG revealed dilated posterior urethra and 
distended thick walled bladder in all cases. 
Hydronephrosis was seen in 39 cases (78%) and hydro-
ureter in 23 cases (46%). Corticomedullary junction 
could be identified in 15 cases. Out of the 25 patients 
who had non visualization of corticomedullary 
junction, 23 had impaired renal function.At 
presentation, 41 patients were treated by bladder 
catheterization and intravenous antibiotics. After 
proper resuscitation with I.V. fluid, correction of 
electrolyte imbalance primary valve fulguration was 
done in 41 cases. We had performed vesicostomy in 9 
cases. So far in this series, vesicostomy closure has 
been done in 7 cases and 2 patients are waiting with 
open stoma. Complications of vesicostomy were 
wound infection, stomal stenosis and mild prolapse. 
One patient presented with acute renal failure and was 
treated with haemodialysis; the patient improved on 
dialysis and is doing well till date. No patient was died 
in our series. Two patients of our series were suffering 
from persistent septicaemia after valve ablation. They 
were treated with high dose antibiotics. At present they 
are doing well.Another patient of our series developed 
urethral stricture after cystoscopic valve fulguration. At 
present he is doing well after cystoscopic dilatation of 
urethra. We discharge the patient with prophylactic 
antibiotics (usually Co-trimoxazole) for 3 months with 
advice to visit surgery OPD monthly for 3 months with 
RE and C/S report and blood urea and creatinine report 
[Table 6]. If culture C/S report of urine showed no 
growth for 3 consecutive months, then we stopped the 
antibiotics with advice of second follow up after 3 
months with MCU, USG- Abdomen and KUB and 
third follow up after another 6 months with blood urea, 
serum creatinine, RE and C/S. We used to prescribe 
either oxybutynine or Imipramine for 3 months in all 
patients at the time of discharge.In the follow-up at one 
month serum creatinine level came down in 39 patients 
out of 50 patients. Creatinine level at presentation was 
between 1-2 mg/dl in 29 patients between > 2-3 mg/dl 
in 11 patients and > 3 mg/dl in 10 patients. At one year 
follow-up, out of 43 patients, only 2 patients had serum 
creatinine level > 2 mg/dl. At the second year follow-
up, out of 40 patients, 1 patient had creatinine level > 2 
mg/dl [Table 7]. Follow-up MCU in 1 case who had 
Grade-I reflux showed resolution within 2 years and 
grade of reflux improved in 7 other cases. DTPA renal 
scan was performed in 37 cases all of which showed 
bilateral hydronephrosis mild to moderate degree. 
Perfusion was low and there was gross delayed 
excretory pattern. GFR reduced in affected kidneys. As 
a routine follow-up first DTPA scan was performed at 
6 months after cystoscopic valve fulgaration. Three 
patients showed improvement of excretory pattern in 
first follow-up DTPA renal scan. Urodynamic study 
was done in 5 cases where serum creatinine level 
remained above 2 mg/dl but below 5 mg/dl or in 
patients having residual symptoms after adequate 
primary cystoscopic valve fulguration. 
 
Discussion 
 
The reported incidence of PUV is 1 in 80006 
to 1 in 250001 live births. In our institution with about 
450 paediatric surgical admission per year we admitted 
approximately 27 cases of PUV annually. 
Approximately one third of PUV patients presented 
during the neonatal period and age between 5 years and 
12 years, one third between 1 month and 2 years and 
one third between 2 years and 5 years of age. [18, 19, 
20] More recent reviews have demonstrated increased 
presentation during the neonatal period and this early 
presentation is attributed to greater awareness about the 
condition and better antenatal diagnosis[1]. PUV is 
increasingly recognized by routine pre-natal USG. [1, 
21, 22] The characteristic findings are bilateral 
hydronephrosis and a distended thickened bladder. A 
dilated posterior urethra is seen occasionally. Low 
amniotic fluid and bright renal parenchyma [suggestive 
of dysplasia] provide important clues about the severity 
of renal damage. In our series, on routine antenatal 
USG, one fetus was suspected of having PUV due to 
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presence of bilateral hydronephrosis and 
oligohydramnios and postnatally we confirmed the 
diagnosis by MCU and USG. The baby was managed 
by primary cystoscopic fulguration and he is doing 
well on subsequent follow up. 
Whether prenatal diagnosis has any impact on 
long term follow up is still controversial[18]. Failure of 
prenatal diagnosis to improve outcomes has been 
observed in multiple studies over the years. [23-25] 
Even in the developed world, fetal intervention is 
practiced in a few selective centres only. The beneficial 
effect of fetal intervention in PUV is, as yet, unproven. 
However, antenatal diagnosis does help to plan the 
delivery of the baby in a suitably equipped institute 
where early confirmation of the diagnosis and 
treatment may prevent future complications. In our 
series 14% patients presented within 1 month, 22% 
patients presented within 1 month to 2 years, 44% 
patients were in the age group of 2 years to 5 years and 
20% patients were between 5 years to 12 years. The 
majority of the patients presented between 2 years to 5 
years of age and this report are not consistent with 
other reports[18,26] published in literature. In neonates 
obstructive symptoms (straining, poor stream, dribbling 
of urine) may be seen in 100% cases and many of them 
present with features of renal failure[1, 20] 
Infants present with features of infection 
(78%) like septicaemic shock, poor feeding, abdominal 
pain and positive urine culture[20]. They also present 
with abdominal distension, dribbling of urine (100%), 
failure to thrive (30%) and palpable kidney (18%)[21]. 
In toddler, renal failure becomes less common but 
voiding symptoms and infection predominates. 100% 
patients over 5 years of age present with 
dribbling[1].These later presentation is indicative of 
milder forms of valvular obstruction and their 
presentation may be delayed upto adulthood[27]. 
In our series obstructive symptoms in the form of poor 
urinary stream and dribbling were present in all cases. 
In 5 patients who were of older age group, the 
symptoms were present for a short period, 18% patients 
presented with a palpable kidney and 54% patients 
presented with recurrent UTI. Renal failure was more 
common in those who presented at an earlier age.  
In our series 7 patients presented with renal 
failure and one of them presented 
with features of renal rickets. Failure to thrive 
observed in 30% of patients. The PUV cases may be 
associated with several types of anomalies. In our 
series, 9 out of 50 patients were associated with various 
types of anomalies.2 Patients out of 9 patients has 
multiple anomalies (listed in Table 3). 
The incidence of anomalies encountered in 
our series is 18%. The anomalies were treated 
accordingly after cystoscopic valve ablation (discussed 
in results and analysis chapter). USG demonstrates 
hydronephrosis, thick walled bladder, dilated posterior 
urethra and occasionally bright kidneys with loss of 
cortico-medullary differentiation suggestive of renal 
dysplasia[28]. In our series cortico-medullary junction 
was demarcated in 15 cases (30%) cases while the 
demarcation was lost in 25 cases (50%). MCU/VCUG 
is the “gold standard” in diagnosis of case of posterior 
urethral valves. It permits assessment of vesico-ureteric 
reflux in almost 50% patients[29]. Of these, 20% will 
have renal dysplasia[18].In 15%, there is spontaneous 
resolution of reflux and in the remaining 15% reflux 
persists and needs surgical correction[30]. 
In our series 19 patients (38%) presented with 
reflux and during a short follow up. (Approximately 2 
years) 1 patient with grade-I reflux showed resolution 
and grade of reflux improved in 7 other cases. 
Unsatisfactory previous scan experience, long distance 
to service providers, and long waiting periods have 
been identified as major obstacles to prenatal 
diagnosis[31].There was a time when many centres 
performed urinary diversions due to non availability of 
small-sized resectoscope. But as these are available 
now, trans-urethral fulguration of valve is the treatment 
of choice in PUV patients, even in neonates. The long 
term policy of diversion has been questioned by 
some[32].The role of different types of vesical and 
supra-vesical diversion is controversial[5]. 
The incidence of urinary diversion in the 
primary management of posterior urethral valves is 
very high, about 50% in the majority of Indian centres. 
The difference in the management of PUV between the 
developing world and the developed world is the rate 
of diversion. Inspite of high urinary diversion rate and 
subsequent surgery, the mortality has declined in our 
country, which signified that diversion has a role to 
play in decompressing the upper urinary tract and to 
control the infection. Inspite of few complications, 
vesicostomy is preferred for short term diversion 
though supra-vesical drainage is restricted to patients 
with poor renal function and infection due to dilated 
tortuous ureter or vesico-ureteric reflux as evident in 
the majority of Indian articles. A similar experience has 
also been reported from Hospital for Sick children, 
Toronto[5].We have found that vesicostomy is very 
useful methods of diversion, as functioning 
vesicostomy provide an adequate drainage of the lower 
urinary tract as proposed by Duckett[33,34]. It is a 
minimally invasive surgery and is an easily reversible 
technique. It allows cycling of the bladder to take place 
at low pressures[35].Ureterostomy on the other hand is 
more difficult to perform but has the advantage of 
better decompression of the kidney[38].Bilateral 
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ureterostomy was advocated by some authors as a 
better alternative method of diversion in developing 
countries, for patients with persistently high serum 
creatinine level.[36] Creatinine after operative 
intervention for PUVs is a well-known predictor of 
long-term renal function[37,38]. We have done primary 
cystoscopic valve fulguration in 41 cases (82%) and 
vesicostomy followed by cystoscopic fulguration in 
rest of 9 cases (18%). However in our series we did not 
performed ureterostomy. Reoperation rates have been 
widely studied for many urological interventions, 
including transurethral incision of ureteroceles147-148 
and proximal hypospadias repair[39,40]. 
This is an ongoing study. Clinical parameters 
and investigations of 50 patients of our series, over a 
period of 2 years are being presented for a disease like 
PUV which has varied manifestation. Long term 
follow-up is necessary to see the effect of treatment in 
these patients. Aggressive management of vesico-
ureteric reflux with early surgical intervention is rarely 
justified as upper urinary tract complications resolve 
spontaneously in some cases. In our short term follow-
up we have observed resolution of reflux in 1 case with 
improved reflux in other cases. 
 
Conclusion 
 
The diagnosis of posterior urethral valve is 
well suspected by USG both antenatally and post-
natally. The diagnosis of posterior urethral valves as 
well VUR should always be confirmed by MCU. The 
management of posterior urethral valves at the first 
outlet should be urethral catheterization and 
stabilization of the general condition followed by 
primary valve ablation by any means. For those who 
are not progressing satisfactorily, a second attempt of 
valve ablation may be of great help. The cystoscopic 
valve fulguration at 5, 7 and 12 O’clock position is not 
desirable at same sitting. Diversion may be done before 
fulguration as a temporary measure for upper urinary 
tract decompression with good result. The DTPA scan 
is most important tool in assessing the result of 
management during follow-up. But in our opinion it 
cannot replace the simple way of assessing the renal 
functional status by serial estimation of serum 
creatinine and regular microscopic urinary examination 
for per cells. Though loop cutaneous ureterostomy is a 
better option than cutaneous vesicostomy besides that, 
in our opinion cutaneous vesicostomy is a suitable 
alternative to loop cutaneous ureterostomy because – 
a) Technically easier to perform 
b) Eliminates reflux 
c) Preserves the integrity of ureters and maintain 
bladder cycles. 
Serum creatinine value at presentation is not predictive 
of subsequent renal functional status, but creatinine 
value after a brief period of urinary decompression is 
prognostically more useful. Dedicated regular follow 
up and proper assessment after diagnosing and 
fulgurating the valve, with sympathetic attitude to these 
children and their families is very much essential for 
better outcome to the patients with posterior urethral 
valves. 
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